• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物转化综述:在眼部疾病和药物设计中的应用

Biotransformation in review: applications in ocular disease and drug design.

作者信息

Gaynes B I, Fiscella R G

机构信息

Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, USA.

出版信息

J Ocul Pharmacol Ther. 1996 Winter;12(4):527-39. doi: 10.1089/jop.1996.12.527.

DOI:10.1089/jop.1996.12.527
PMID:8951689
Abstract

The purpose of this paper is to review the biochemical processes of systemic biotransformation and describe their relevance to ocular disease and drug metabolism. The diverse nature of the biochemical pathways, commonly found in enzyme metabolism, is discussed. The occurrence of these processes in the eye has significance in that the products of metabolism may accumulate locally and exert deterimental effects, presumably by altering the cellular structure and/or function of crucial visual elements. The manipulation of these metabolic pathways within the eye has ramifications in the development of novel drug design for both ocular disease treatment and, perhaps more importantly, disease prevention.

摘要

本文的目的是回顾全身生物转化的生化过程,并描述它们与眼部疾病和药物代谢的相关性。文中讨论了酶代谢中常见的生化途径的多样性。这些过程在眼部的发生具有重要意义,因为代谢产物可能在局部积累并产生有害影响,推测是通过改变关键视觉元件的细胞结构和/或功能。在眼内对这些代谢途径进行调控,对于开发用于眼部疾病治疗以及或许更重要的疾病预防的新型药物设计具有影响。

相似文献

1
Biotransformation in review: applications in ocular disease and drug design.生物转化综述:在眼部疾病和药物设计中的应用
J Ocul Pharmacol Ther. 1996 Winter;12(4):527-39. doi: 10.1089/jop.1996.12.527.
2
Lead optimization strategies as part of a drug metabolism environment.作为药物代谢环境一部分的先导化合物优化策略。
Curr Opin Drug Discov Devel. 2003 Jul;6(4):481-5.
3
Overcoming ocular drug delivery barriers through the use of physical forces.通过物理作用力克服眼部药物输送障碍。
Adv Drug Deliv Rev. 2018 Feb 15;126:96-112. doi: 10.1016/j.addr.2017.09.008. Epub 2017 Sep 12.
4
[Liver and metabolism of drugs].[肝脏与药物代谢]
Cah Med. 1974 Oct 15;15(10):637-43.
5
Role of pharmacologically active metabolites in drug discovery and development.药理活性代谢物在药物发现与开发中的作用。
Drug Discov Today. 2006 Feb;11(3-4):133-42. doi: 10.1016/S1359-6446(05)03681-0.
6
High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.药物代谢与药代动力学中的高通量筛选对药物发现的支持。
Annu Rev Pharmacol Toxicol. 2000;40:133-57. doi: 10.1146/annurev.pharmtox.40.1.133.
7
Bioactivation of drugs: risk and drug design.药物的生物活化:风险与药物设计。
Annu Rev Pharmacol Toxicol. 2011;51:145-67. doi: 10.1146/annurev-pharmtox-010510-100514.
8
Safe prescribing in liver disease.肝病的安全处方
Br Med J. 1973 Apr 28;2(5860):193-4.
9
Practical pharmacokinetics as part of clinical pharmacology.实用药代动力学作为临床药理学的一部分。
Int Z Klin Pharmakol Ther Toxikol. 1970 Dec;4(1):37-41.
10
Chirality in new drug development. Clinical pharmacokinetic considerations.
Clin Pharmacokinet. 1994 Oct;27(4):249-55. doi: 10.2165/00003088-199427040-00001.

引用本文的文献

1
Profiling tear film enzymes reveals major metabolic pathways involved in the homeostasis of the ocular surface.分析泪膜酶可揭示参与眼表面内稳态的主要代谢途径。
Sci Rep. 2023 Sep 14;13(1):15231. doi: 10.1038/s41598-023-42104-2.
2
Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.用于眼科的局部用非甾体抗炎药:安全性综述。
Drug Saf. 2002;25(4):233-50. doi: 10.2165/00002018-200225040-00002.